MYB and breast cancer: One of the in silico predicted targets for let-7c was the proliferation promoting transcription factor Myb which has been shown to be overexpressed in colon and breast cancer and our experimental data support the notion that let-7c has a negative effect on Myb mRNA and protein expression in both CCH cells and MCF-7 cells [21].